Gundersen Health System invests in Minnesota-based gene editing firm
Gundersen Health System was the lead investor in the most recent funding round for a Minnesota-based company that’s focused on using gene editing to improve treatment for diseases and regenerative medicine.
To access this content, you must purchase a Premium membership, or log in if you are a member.
